List of Tables
Table 1. Global Anti-allergic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral Drugs
Table 3. Key Players of Non-Oral Drugs
Table 4. Global Anti-allergic Drugs Market Size Growth by Sales Channel (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Anti-allergic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Anti-allergic Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Anti-allergic Drugs Market Share by Region (2020-2025)
Table 8. Global Anti-allergic Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Anti-allergic Drugs Market Share by Region (2026-2031)
Table 10. Anti-allergic Drugs Market Trends
Table 11. Anti-allergic Drugs Market Drivers
Table 12. Anti-allergic Drugs Market Challenges
Table 13. Anti-allergic Drugs Market Restraints
Table 14. Global Anti-allergic Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Anti-allergic Drugs Market Share by Players (2020-2025)
Table 16. Global Top Anti-allergic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-allergic Drugs as of 2024)
Table 17. Ranking of Global Top Anti-allergic Drugs Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Anti-allergic Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Anti-allergic Drugs, Headquarters and Area Served
Table 20. Global Key Players of Anti-allergic Drugs, Product and Application
Table 21. Global Key Players of Anti-allergic Drugs, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-allergic Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Anti-allergic Drugs Revenue Market Share by Type (2020-2025)
Table 25. Global Anti-allergic Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Anti-allergic Drugs Revenue Market Share by Type (2026-2031)
Table 27. Global Anti-allergic Drugs Market Size by Sales Channel (2020-2025) & (US$ Million)
Table 28. Global Anti-allergic Drugs Revenue Market Share by Sales Channel (2020-2025)
Table 29. Global Anti-allergic Drugs Forecasted Market Size by Sales Channel (2026-2031) & (US$ Million)
Table 30. Global Anti-allergic Drugs Revenue Market Share by Sales Channel (2026-2031)
Table 31. North America Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Anti-allergic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Anti-allergic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Anti-allergic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Anti-allergic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Anti-allergic Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Anti-allergic Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Anti-allergic Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Anti-allergic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Anti-allergic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Anti-allergic Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Anti-allergic Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Sanofi Company Details
Table 47. Sanofi Business Overview
Table 48. Sanofi Anti-allergic Drugs Product
Table 49. Sanofi Revenue in Anti-allergic Drugs Business (2020-2025) & (US$ Million)
Table 50. Sanofi Recent Development
Table 51. Johnson And Johnson Company Details
Table 52. Johnson And Johnson Business Overview
Table 53. Johnson And Johnson Anti-allergic Drugs Product
Table 54. Johnson And Johnson Revenue in Anti-allergic Drugs Business (2020-2025) & (US$ Million)
Table 55. Johnson And Johnson Recent Development
Table 56. Merck Company Details
Table 57. Merck Business Overview
Table 58. Merck Anti-allergic Drugs Product
Table 59. Merck Revenue in Anti-allergic Drugs Business (2020-2025) & (US$ Million)
Table 60. Merck Recent Development
Table 61. Teva Company Details
Table 62. Teva Business Overview
Table 63. Teva Anti-allergic Drugs Product
Table 64. Teva Revenue in Anti-allergic Drugs Business (2020-2025) & (US$ Million)
Table 65. Teva Recent Development
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Anti-allergic Drugs Product
Table 69. GlaxoSmithKline Revenue in Anti-allergic Drugs Business (2020-2025) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Bayer Company Details
Table 72. Bayer Business Overview
Table 73. Bayer Anti-allergic Drugs Product
Table 74. Bayer Revenue in Anti-allergic Drugs Business (2020-2025) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Sun Pharma Company Details
Table 77. Sun Pharma Business Overview
Table 78. Sun Pharma Anti-allergic Drugs Product
Table 79. Sun Pharma Revenue in Anti-allergic Drugs Business (2020-2025) & (US$ Million)
Table 80. Sun Pharma Recent Development
Table 81. UCB Pharma Company Details
Table 82. UCB Pharma Business Overview
Table 83. UCB Pharma Anti-allergic Drugs Product
Table 84. UCB Pharma Revenue in Anti-allergic Drugs Business (2020-2025) & (US$ Million)
Table 85. UCB Pharma Recent Development
Table 86. Yangtze River Pharmaceutical Group Company Details
Table 87. Yangtze River Pharmaceutical Group Business Overview
Table 88. Yangtze River Pharmaceutical Group Anti-allergic Drugs Product
Table 89. Yangtze River Pharmaceutical Group Revenue in Anti-allergic Drugs Business (2020-2025) & (US$ Million)
Table 90. Yangtze River Pharmaceutical Group Recent Development
Table 91. Hainan Poly Pharm Company Details
Table 92. Hainan Poly Pharm Business Overview
Table 93. Hainan Poly Pharm Anti-allergic Drugs Product
Table 94. Hainan Poly Pharm Revenue in Anti-allergic Drugs Business (2020-2025) & (US$ Million)
Table 95. Hainan Poly Pharm Recent Development
Table 96. Chongqing Huapont Pharmaceutical Company Details
Table 97. Chongqing Huapont Pharmaceutical Business Overview
Table 98. Chongqing Huapont Pharmaceutical Anti-allergic Drugs Product
Table 99. Chongqing Huapont Pharmaceutical Revenue in Anti-allergic Drugs Business (2020-2025) & (US$ Million)
Table 100. Chongqing Huapont Pharmaceutical Recent Development
Table 101. Dawnrays Company Details
Table 102. Dawnrays Business Overview
Table 103. Dawnrays Anti-allergic Drugs Product
Table 104. Dawnrays Revenue in Anti-allergic Drugs Business (2020-2025) & (US$ Million)
Table 105. Dawnrays Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Anti-allergic Drugs Picture
Figure 2. Global Anti-allergic Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-allergic Drugs Market Share by Type: 2024 VS 2031
Figure 4. Oral Drugs Features
Figure 5. Non-Oral Drugs Features
Figure 6. Global Anti-allergic Drugs Market Size by Sales Channel (2020-2031) & (US$ Million)
Figure 7. Global Anti-allergic Drugs Market Share by Sales Channel: 2024 VS 2031
Figure 8. Online Case Studies
Figure 9. Offline Case Studies
Figure 10. Anti-allergic Drugs Report Years Considered
Figure 11. Global Anti-allergic Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Anti-allergic Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Anti-allergic Drugs Market Share by Region: 2024 VS 2031
Figure 14. Global Anti-allergic Drugs Market Share by Players in 2024
Figure 15. Global Top Anti-allergic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-allergic Drugs as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Anti-allergic Drugs Revenue in 2024
Figure 17. North America Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Anti-allergic Drugs Market Share by Country (2020-2031)
Figure 19. United States Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Anti-allergic Drugs Market Share by Country (2020-2031)
Figure 23. Germany Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Anti-allergic Drugs Market Share by Region (2020-2031)
Figure 31. China Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Anti-allergic Drugs Market Share by Country (2020-2031)
Figure 39. Mexico Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Anti-allergic Drugs Market Share by Country (2020-2031)
Figure 43. Turkey Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Anti-allergic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Sanofi Revenue Growth Rate in Anti-allergic Drugs Business (2020-2025)
Figure 47. Johnson And Johnson Revenue Growth Rate in Anti-allergic Drugs Business (2020-2025)
Figure 48. Merck Revenue Growth Rate in Anti-allergic Drugs Business (2020-2025)
Figure 49. Teva Revenue Growth Rate in Anti-allergic Drugs Business (2020-2025)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Anti-allergic Drugs Business (2020-2025)
Figure 51. Bayer Revenue Growth Rate in Anti-allergic Drugs Business (2020-2025)
Figure 52. Sun Pharma Revenue Growth Rate in Anti-allergic Drugs Business (2020-2025)
Figure 53. UCB Pharma Revenue Growth Rate in Anti-allergic Drugs Business (2020-2025)
Figure 54. Yangtze River Pharmaceutical Group Revenue Growth Rate in Anti-allergic Drugs Business (2020-2025)
Figure 55. Hainan Poly Pharm Revenue Growth Rate in Anti-allergic Drugs Business (2020-2025)
Figure 56. Chongqing Huapont Pharmaceutical Revenue Growth Rate in Anti-allergic Drugs Business (2020-2025)
Figure 57. Dawnrays Revenue Growth Rate in Anti-allergic Drugs Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
